Stay updated on Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial
Sign up to get notified when there's something new on the Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial page.

Latest updates to the Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial page
- Check4 days agoChange DetectedThe completed Phase 3 avatrombopag study record is displayed, with details on its design, eligibility criteria, treatment arms, outcomes, participating locations, and related documents.SummaryDifference64%

- Check11 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA sitewide banner announces NIH website updates and a terminology change related to Executive Order 14434. The site revision label advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0. The study record remains inaccessible with a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating an access restriction to the study record. This blocks viewing the study content.SummaryDifference17%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0. This reflects a minor update to the study record’s metadata rather than substantive changes to the trial data or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avatrombopag for CTC-Induced Thrombocytopenia Clinical Trial page.